国际肿瘤学杂志
國際腫瘤學雜誌
국제종류학잡지
JOURNAL OF INTERNATIONAL ONCOLOGY
2015年
8期
622-624
,共3页
乳腺肿瘤%受体,成纤维细胞生长因子,3 型
乳腺腫瘤%受體,成纖維細胞生長因子,3 型
유선종류%수체,성섬유세포생장인자,3 형
Breast neoplasms%Receptor,fibroblast growth factor,type 3
成纤维细胞生长因子受体3(FGFR3)在调节细胞的增殖、分化及血管形成中发挥重要作用。近年来,研究发现 FGFR3在乳腺癌发生发展和内分泌治疗耐药性乳腺癌中发挥一定的作用,并且与乳腺癌患者的预后密切相关。
成纖維細胞生長因子受體3(FGFR3)在調節細胞的增殖、分化及血管形成中髮揮重要作用。近年來,研究髮現 FGFR3在乳腺癌髮生髮展和內分泌治療耐藥性乳腺癌中髮揮一定的作用,併且與乳腺癌患者的預後密切相關。
성섬유세포생장인자수체3(FGFR3)재조절세포적증식、분화급혈관형성중발휘중요작용。근년래,연구발현 FGFR3재유선암발생발전화내분비치료내약성유선암중발휘일정적작용,병차여유선암환자적예후밀절상관。
Fibroblast growth factor receptor 3(FGFR3)plays important roles in cell proliferation,diffe rentiation,and angiogenesis.Recent studies have demonstrated that FGFR3 is associated with progression of breast cancer and has effects in endocrine therapy resistance breast cancer.It has also been showed that FGFR3 is correlated with breast cancer prognosis.